Fingerprint
Dive into the research topics of 'Stopping Mesalamine Therapy in Patients With Crohn's Disease Starting Biologic Therapy Does Not Increase Risk of Adverse Outcomes'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Stopping Mesalamine Therapy in Patients With Crohn's Disease Starting Biologic Therapy Does Not Increase Risk of Adverse Outcomes
Ryan C. Ungaro, Berkeley N. Limketkai, Camilla Bjørn Jensen, Clara Yzet, Kristine H. Allin, Manasi Agrawal, Thomas Ullman, Johan Burisch, Tine Jess, Jean Frederic Colombel
Research output: Contribution to journal › Article › peer-review
18
Scopus
citations